SKIN TUMORIGENESIS BY 7,12-DIMETHYLBENZ(A)ANTHRACENE: INHIBITION BY ACTINOMYCIN D

Science (New York, N.Y.)
|September 18, 1964
PubMed

Insights

Topical actinomycin D application significantly prevents tumor formation after exposure to 7,12-dimethyl-benz(a)anthracene. This suggests early carcinogenesis relies on DNA-dependent RNA synthesis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Carcinogenesis involves complex molecular events initiated by exposure to carcinogens.
  • Understanding the early stages of cancer development is crucial for prevention and treatment strategies.

Purpose of the Study:

  • To investigate the role of DNA-dependent RNA synthesis in the initial phase of chemical carcinogenesis.
  • To evaluate the inhibitory effect of actinomycin D on tumor formation induced by 7,12-dimethyl-benz(a)anthracene.

Main Methods:

  • Topical administration of actinomycin D.
  • Application of 7,12-dimethyl-benz(a)anthracene.
  • Monitoring of subsequent tumor formation.

Main Results:

  • Actinomycin D, applied shortly before and after 7,12-dimethyl-benz(a)anthracene exposure, markedly inhibited tumor development.
  • The findings highlight the critical involvement of DNA-dependent RNA synthesis in early carcinogenesis.

Conclusions:

  • Initial carcinogenic events are dependent on DNA-dependent RNA synthesis.
  • Targeting RNA synthesis may offer a strategy for cancer chemoprevention.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...